Combination treatment with interferon (IFN) and ribavirin (RBV) for hepatitis C (HCV) in HIV co-infection patients.

被引：0
|
作者：
Dieterich, DT
Weisz, KB
Goldman, DJ
Malicdem, ML
机构：
[1] Cabrini Med Ctr, New York, NY USA
[2] Liberty Med LLP, New York, NY USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
422
引用
下载
收藏
页码：266A / 266A
页数：1
相关论文
共 50 条
  • [41] Combination of interferon (IFN) α-2a and ribavirin therapy in chronic hepatitis C infection (HCV) after ineffective interferon α-2a monotherapy
    Perdita, W
    Ramadori, G
    GASTROENTEROLOGY, 1999, 116 (04) : A1261 - A1261
  • [42] Hepatitis B and C co-infection in HIV patients
    Sarita Bajaj
    Manisha Dwivedi
    Sri Prakash Misra
    Rajpal Prajapati
    Indian Journal of Gastroenterology, 2012, 31 (6) : 349 - 350
  • [43] Hepatitis B and C co-infection in HIV patients
    Bajaj, Sarita
    Dwivedi, Manisha
    Misra, Sri
    Prajapati, Rajpal
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2012, 31 (06) : 349 - 350
  • [44] Care of patients with hepatitis C and HIV co-infection
    Soriano, V
    Puoti, M
    Sulkowski, M
    Mauss, S
    Cacoub, P
    Cargnel, A
    Dieterich, D
    Hatzakis, A
    Rockstroh, J
    AIDS, 2004, 18 (01) : 1 - 12
  • [45] Combination interferon and ribavirin treatment for chronic hepatitis C virus (HCV) infected patients with no fibrosis.
    Delahooke, TE
    Miller, M
    Blair, CJ
    Harrison, DJ
    Hayes, PC
    HEPATOLOGY, 1999, 30 (04) : 625A - 625A
  • [46] Interferon (IFN) induction followed by prolonged high dose IFN in combination with ribavirin (RBV) for relapser HCV patients: A randomized controlled multicenter trial
    Fattovich, G
    Zagni, I
    Fornaciari, G
    Minola, E
    Fabris, P
    Boccia, S
    Giusti, M
    Abbati, G
    Felder, M
    Rovere, P
    Redaelli, A
    Tonon, A
    Montanari, M
    Paternoster, C
    Buscarini, E
    Castagnetti, E
    Tositti, G
    Rizzo, C
    Suppressa, S
    Pantalena, M
    Fa, F
    JOURNAL OF HEPATOLOGY, 2001, 34 : 147 - 147
  • [47] Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation
    Hartwell, Debbie
    Jones, Jeremy
    Baxter, Louise
    Shepherd, Jonathan
    HEALTH TECHNOLOGY ASSESSMENT, 2011, 15 (17) : 1 - +
  • [48] An open, multicenter, randomized trial comparing pegylated interferon alpha-2b (PEG-IFN) plus ribavirin (RBV) versus PEG-IFN for treatment of HIV/HCV co-infected patients.
    Cargnel, A
    Angeli, E
    Casella, A
    Gubertini, G
    Mainini, A
    Orlando, G
    Duca, P
    HEPATOLOGY, 2002, 36 (04) : 363A - 363A
  • [49] The combination of pegylated interferon (PEG-IFN) and ribavirin (RIBA) in the treatment of chronic hepatitis C (HCV) infection: Preliminary report of a single centre experience
    Kanagasabai, G
    Heydtmann, M
    O'Donnell, K
    Harrison, R
    Mutimer, D
    GUT, 2002, 50 : A117 - A118
  • [50] HIV and hepatitis C co-infection
    Matthews, Gail V.
    Dore, Gregory J.
    ASIAN BIOMEDICINE, 2009, 3 (01) : 29 - 37
12345